Health Topics: Page 5

Alzheimer’s drug approval poised to reshape APOE testing market

By Nick Paul Taylor

The U.S. Food and Drug Administration (FDA) approval of Biogen and Eisai’s Alzheimer’s disease drug Leqembi is likely to drive changes in the APOE testing market, according to an article in GenomeWeb.

September 25, 2023

Protein biomarker may aid in early Parkinsonian disorders detection

By LabPulse.com staff writers

A protein biomarker present in cerebrospinal fluid and blood plasma may be useful for the early diagnosis of Parkinsonian disorders.

September 21, 2023

NIH’s systematic review finds AI may improve detection of underdiagnosed condition

By Nick Paul Taylor

A systematic review of earlier studies has found that artificial intelligence (AI) and machine learning (ML) can support the diagnosis of polycystic ovarian syndrome (PCOS).

September 19, 2023

Experts raise concerns about Quest Diagnostics’ consumer-initiated Alzheimer’s test

By Nick Paul Taylor

Experts have raised concerns about Quest Diagnostics’ $399 consumer-initiated Alzheimer’s disease test, telling 360Dx that it is unclear whether the product is accurate enough to support its use.

September 15, 2023

U.K. charity to offer $1.6M in grants for research on muscle-wasting diseases

By Matt Limb

U.K. research projects will benefit from 1.3 million pounds ($1.6 million) in grants to improve diagnostic testing and potential new treatments for muscle-wasting and -weakening conditions.

September 14, 2023

Researchers link changes in lipids to human health, disease, and aging

By Nick Paul Taylor

Researchers have tracked changes to lipids during respiratory viral infection, insulin resistance, and aging, suggesting that the fats may play a role in immune homoeostasis and inflammation regulation.

September 13, 2023

Autologous cell therapy improves outcomes in COPD patients in small trial

By Nick Paul Taylor

Treating chronic obstructive pulmonary disease (COPD) patients with their own cells improved outcomes in an early-phase clinical trial, encouraging the researchers to plan a larger study.

September 14, 2023

Identification of hundreds of blood pressure genes lays foundation for hypertension drugs

By Nick Paul Taylor

Researchers have found hundreds of genes that may affect blood pressure, setting the stage for further studies that could inform the development of new treatments for hypertension.

September 12, 2023

Proteomics study finds plasma proteins linked with type 2 diabetes, diabetic complications

By Matt Limb

An analysis of plasma proteins found to be linked with type 2 diabetes and diabetic complications may help develop therapeutic targets, researchers write in an article published in Cell Reports Medicine.

September 8, 2023

Cell-free DNA methylation blood test predicts risk of early-onset preeclampsia

By Nick Paul Taylor

Cell-free DNA methylation profiling may support the presymptomatic assessment of preeclampsia (PE) risk, according to a paper published on August 28 in Nature Medicine.

August 30, 2023

C2N Diagnostics rolls out second-generation Alzheimer's disease biomarker test

By Matt Limb

C₂N Diagnostics has unveiled its “next generation” blood biomarker test to evaluate patients with signs and symptoms of Alzheimer’s disease (AD) and other causes of cognitive decline.

August 29, 2023

AI neuroimaging model aims to predict neuropathic pain treatment responses

By Matt Limb

A magnetic resonance (MR) neuroimaging model which uses artificial intelligence (AI) to identify new biomarkers could lead to more effective medical treatment for chronic nerve pain, say the researchers developing the model.

August 25, 2023

Previous Page

Page 5 of 69

Next Page